An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670)in β-thalassemia Patients With Transfusional Iron Overload

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT00171210

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:35:10.844535+00:00

Published At

2011-05-02T00:00:00+00:00

Record Updated At

2011-05-30

Results Posted At

2011-05-02

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Transfusional Iron Overload in \u03b2-thalassemia"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2011-05-30"

protocolSection.identificationModule.nctId

"NCT00171210"

protocolSection.identificationModule.officialTitle

"An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670)in \u03b2-thalassemia Patients With Transfusional Iron Overload"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE3"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2011-05-02"

Study condition terms

• Transfusional Iron Overload in β-thalassemia (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.